Literature DB >> 20139065

Impact of peritoneal transport characteristics on cardiac function in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report.

Sevcan A Bakkaloglu1, Arda Saygili, Lale Sever, Nejat Aksu, Aytul Noyan, Sema Akman, Mesiha Ekim, Beyza Doganay, Nurdan Yildiz, Figen Akalin, Salim Caliskan, Orhan D Kara, Ali Duzova, Alper Soylu, Semra Atalay.   

Abstract

BACKGROUND: The peritoneal equilibration test (PET) is recommended in paediatric peritoneal dialysis (PD) patients to assist prescription management. Despite contradictory reports, high transporter status is associated with reduced survival rate in adults. Since cardiac disease is one of the main causes of mortality in paediatric PD patients, we aimed to evaluate whether transport features have any effect on biochemical data and cardiac function in this group.
METHODS: One hundred and ten PD patients (13 +/- 5 years, PD vintage: 31 +/- 27 months) were enrolled into the study. Four-hour dialysate/plasma creatinine ratio was used for differentiating PET groups. Thirty-eight patients were high transporters, 29 were high-average transporters and 43 were low-average/low transporters. Echocardiography was performed in all subjects.
RESULTS: Age, PD vintage, dialysate glucose concentration, ultrafiltration volume, urine volume and blood pressure levels were similar in all PET groups. No biochemical or echocardiographic data (ejection fraction, fractional shortening, left ventricular mass index, myocardial performance index, power Doppler E/tissue Doppler E ratio reflecting diastolic function) were different among PET groups except lower albumin (P = 0.025) levels in high transporters and higher high-sensitivity C-reactive protein (P = 0.026) levels in high and high-average transporters compared to other transport groups.
CONCLUSIONS: Cardiac structural and functional abnormalities are highly prevalent among paediatric PD patients. Transport rates did not have a significant effect on biochemical parameters or cardiac structural/functional parameters. It might be suggested that being a high transporter does not provide a disadvantage in terms of atherogenic tendency and cardiac disease in paediatric PD patients. Oligoanuria, anaemia and hypertension were independent predictors of cardiac disease.

Entities:  

Mesh:

Year:  2010        PMID: 20139065     DOI: 10.1093/ndt/gfq027

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

1.  Cardiac geometry in children receiving chronic peritoneal dialysis: findings from the International Pediatric Peritoneal Dialysis Network (IPPN) registry.

Authors:  Sevcan A Bakkaloglu; Dagmara Borzych; Il Soo Ha; Erkin Serdaroglu; Rainer Büscher; Paulina Salas; Hiren Patel; Dorota Drozdz; Karel Vondrak; Andreia Watanabe; Jorge Villagra; Onder Yavascan; Maria Valenzuela; Deborah Gipson; K H Ng; Bradley A Warady; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

2.  Defining left ventricular hypertrophy in children on peritoneal dialysis.

Authors:  Dagmara Borzych; Sevcan A Bakkaloglu; Joshua Zaritsky; Angela Suarez; William Wong; Bruno Ranchin; Cao Qi; Attila J Szabo; Paula A Coccia; Jérôme Harambat; Florin Mitu; Bradley A Warady; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

Review 3.  Peritoneal dialysis in children with end-stage renal disease.

Authors:  Franz Schaefer; Bradley A Warady
Journal:  Nat Rev Nephrol       Date:  2011-09-27       Impact factor: 28.314

4.  Improved blood pressure and left ventricular remodelling in children on chronic intermittent haemodialysis: a longitudinal study.

Authors:  Nabil Melhem; Alex Savis; Arran Wheatley; Helen Copeman; Kay Willmott; Christopher J D Reid; John Simpson; Manish D Sinha
Journal:  Pediatr Nephrol       Date:  2019-05-16       Impact factor: 3.714

5.  Effect of the timing of dialysis initiation on left ventricular hypertrophy and ınflammation in pediatric patients.

Authors:  Sevcan A Bakkaloğlu; Yaşar Kandur; Erkin Serdaroğlu; Aytül Noyan; Aysun Karabay Bayazıt; Lale Sever; Sare Gülfem Özlü; Gül Özçelik; İsmail Dursun; Caner Alparslan
Journal:  Pediatr Nephrol       Date:  2017-04-10       Impact factor: 3.714

6.  Peritoneal dialysis tailored to pediatric needs.

Authors:  C P Schmitt; A Zaloszyc; B Schaefer; M Fischbach
Journal:  Int J Nephrol       Date:  2011-06-08

Review 7.  Cardiovascular changes during chronic hypertensive states.

Authors:  Dorota Drozdz; Kalina Kawecka-Jaszcz
Journal:  Pediatr Nephrol       Date:  2013-09-12       Impact factor: 3.714

Review 8.  Non-genetic influences on lipoprotein(a) concentrations.

Authors:  Byambaa Enkhmaa; Lars Berglund
Journal:  Atherosclerosis       Date:  2022-05       Impact factor: 6.847

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.